论文部分内容阅读
目的探讨布地奈德联合硫酸特布他林雾化吸入治疗AECOPD临床疗效。方法将COPD急性加重期患者140例,随机分为观察组和对照组进行疗效对比分析。结果两组有效率对比(P<0.05)有显著差异性有统计学意义。结论通过本组数据显示治疗5日后临床有效率,观察组明显高于对照组(P<0.05),说明布地奈德联合硫酸特布他林雾化吸入治疗AECOPD疗效确切,应用简单,耐受性良好,副作用轻微的优点。
Objective To investigate the clinical efficacy of budesonide combined with terbutaline sulfate in the treatment of AECOPD. Methods A total of 140 patients with acute exacerbation of COPD were randomly divided into observation group and control group for comparative analysis. Results There was significant difference between the two groups (P <0.05). Conclusion The clinical data of 5 days after treatment showed that the observation group was significantly higher than that of the control group (P <0.05), indicating that budesonide combined with terbutaline sulphate nebulization for the treatment of AECOPD is effective, simple and tolerable Good, minor side effects.